One of the reasons for failure in advanced ovarian cancer is the escape from antiangiogenic therapy, and both CXCL8 and Bv8 synthesis by TANs has been suggested to be one of the participants [65]. The gene discussed is CXCL8; the disease is ovarian carcinoma.